CSR. WHO criteria for accepting positive PCR test results of H5 infection in humans from national reference laboratories. WHO
Laboratory testing is the only way to confirm that infection with H5 influenza viruses has occurred and is critical for both national H5N1 surveillance activities as well as optimal clinical care in this current period when H5N1 infections remain sporadic. WHO has published recommended laboratory tests to use for confirming influenza A(H5) infectioniii and guidance on the interpretation of test resultsiv. Among these tests, polymerase chain reaction (PCR) is the most common approach used by most laboratories to confirm H5 infection.
However, testing for H5 influenza virus infections is not done routinely by many laboratories. Among laboratories that do test for H5, the levels of experience and diagnostic capacities can vary.
This document provides the necessary criteria by which WHO will accept country reported H5 positive PCR test results as "confirmed".
All countries are urged to share with WHO all H5 positive specimens/virus isolates from humans so that analyses of pandemic risk, development of H5 vaccines, development and updating of diagnostic protocols and reagents, monitoring of antiviral susceptibility patterns and other important risk assessment and response activities can proceed.
However, testing for H5 influenza virus infections is not done routinely by many laboratories. Among laboratories that do test for H5, the levels of experience and diagnostic capacities can vary.
This document provides the necessary criteria by which WHO will accept country reported H5 positive PCR test results as "confirmed".
All countries are urged to share with WHO all H5 positive specimens/virus isolates from humans so that analyses of pandemic risk, development of H5 vaccines, development and updating of diagnostic protocols and reagents, monitoring of antiviral susceptibility patterns and other important risk assessment and response activities can proceed.
See Also:
Latest articles in those days:
- Spatio-temporal dynamics and drivers of highly pathogenic avian influenza H5N1 in Chile 1 days ago
- [preprint] Avian Influenza Virus Infections in Felines: A Systematic Review of Two Decades of Literature 1 days ago
- Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe 1 days ago
- Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older 1 days ago
- Novel Avian Influenza A(H5N6) in Wild Birds, South Korea, 2023 1 days ago
[Go Top] [Close Window]
